🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DMR
$DMRA
🔒 US EquitiesDamora Therapeutics Inc
AVG HISTORICAL GAP
+0.69%
MAX GAP RECORD
+2.60%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DMRA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DMRA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE) |
+1.18%
|
| Mar 19, 2025 Earnings Release 2025-03-19 (AFTER CLOSE) |
-1.75%
|
| Oct 31, 2024 Earnings Release 2024-10-31 (BEFORE OPEN) |
+0.14%
|
| Aug 12, 2024 Earnings Release 2024-08-12 (AFTER CLOSE) |
+2.16%
|
| Apr 29, 2024 Earnings Release 2024-04-29 (AFTER CLOSE) |
-0.28%
|
| Mar 08, 2024 Earnings Release 2024-03-08 (AFTER CLOSE) |
+0.00%
|
| Nov 06, 2023 Earnings Release 2023-11-06 (AFTER CLOSE) |
+0.96%
|
| Jul 31, 2023 Earnings Release 2023-07-31 (AFTER CLOSE) |
+2.60%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.2%
Bullish Gaps (3)
Bearish Gaps (1)
Neutral / Flat (4)
📖 Intelligence Summary
Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2….
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗